Kirsty Purple Book BLA 761188

BLA number
761188
Proprietary names
Kirsty
Proper names
insulin aspart-xjhz
Applicant
Biocon Biologics Inc.
Center
CDER
First observed release
2025-07-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Kirstyinsulin aspart-xjhz351(k) Interchangeable300UNITS/3ML (100UNITS/ML)InjectionSubcutaneousAutoinjectorRxLicensed2025-07-15
002Kirstyinsulin aspart-xjhz351(k) Interchangeable1,000UNITS/10ML (100UNITS/ML)InjectionIntravenous, SubcutaneousMulti-Dose VialRxLicensed2025-07-15

Reference Biological Product#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
020986Novologinsulin aspart351(a)Rx2026-06-01

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2026-05-01U001Kirsty351(k) InterchangeableRxBiocon Biologics Inc.
2026-05-01U002Kirsty351(k) InterchangeableRxBiocon Biologics Inc.
2025-07-01N001Kirsty351(k) InterchangeableRxBiocon Biologics Inc.
2025-07-01N002Kirsty351(k) InterchangeableRxBiocon Biologics Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2025-07-01001Kirsty351(k) InterchangeableRxLicensed2025-07-15
2025-07-01002Kirsty351(k) InterchangeableRxLicensed2025-07-15